"ADVANCING MEDICINE IS OUR PASSION Interested In Finding Cures and Advancing The Future Of Medicine? Miami Clinical Research is an industry leading, full-service clinical research center; Our advanced medical studies aim to improve care and to make life better for others in the future. PARTICIPANTS If you're looking for access to the latest cures and treatments and like the idea of free medical care, then contact us now. Our team of research professionals will help find the right research program for you. DOCTORS If you have a private practice then we give you the opportunity to expose your patients to the latest in medical research and treatments. Refer your patients now and be a part of the future of medicine."

During the past decade, Miami Clinical Research conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 10 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 8 clinical trials were completed. i.e. 72.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Miami Clinical Research" #1 sponsor was "Pfizer" with 3 trials, followed by "Supernus Pharmaceuticals, Inc." with 3 trials sponsored, "American Regent, Inc." with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored and "ALK-Abelló A/S" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Miami Clinical Research" #1 collaborator was "ACM" with 1 trials as a collaborator, "ICON Clinical Research" with 1 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Miami Clinical Research" are "ADHD" (2 trials), "Cardiovascular Disease" (2 trials), "Iron Deficiency Anemia" (2 trials), "Overactive Bladder" (2 trials) and "Allergic Rhinitis Due to Dermatophagoides Farinae" (1 trials). Many other conditions were trialed in "Miami Clinical Research" in a lesser frequency.

Most popular intervention types in "Miami Clinical Research" are "Drug" (15 trials), "Biological" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "400mg SPN-812" (2 trials), "Ferric carboxymaltose" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Miami Clinical Research" are 17 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Miami Clinical Research". undefined are not yet recruiting, 4 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Miami Clinical Research, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Miami Clinical Research, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".